BUY MBP RITUXIMAB MABTAS 500MG INJ. VIAL BEST PRICE ONLINE IN NIGERIA LAGOS ABUJA KANO AND PORTHARCOURT AT MYBIGPHARMACY.COM

Description

Dear friend, this medication requires a prescription or medical license before it can be delivered to you. kindly ensure that you provide us with a reliable contact information at checkout, mybigpharmacy team will be in touch with you to obtain required document before your order is confirmed thank you for trusting mybig pharmacy with your health. RITUXIMAB is a medicine used to treat cancers of the lymphatic system such as non Hodgkin lymphoma and chronic lymphocytic leukaemia, as well as autoimmune diseases like rheumatoid arthritis, vasculitis and some rare immune disorders. RITUXIMAB works on a specific part of the immune system, and I want to help you understand exactly how rituximab behaves in your body, what to expect from rituximab treatment and how we will support you throughout your course of rituximab therapy.

RITUXIMAB is a monoclonal antibody that targets a protein called CD20. This protein is found on the surface of B cells, which are a type of white blood cell. In cancers like lymphoma, these B cells become abnormal and multiply too quickly. In autoimmune diseases, B cells can produce harmful antibodies that trigger inflammation and tissue damage. When rituximab attaches to CD20, it marks the B cell for destruction. Over time, rituximab reduces the number of circulating B cells, helping to control cancer growth or reduce harmful immune activity. New B cells eventually grow back, usually in a more balanced and controlled way.

RITUXIMAB is given as an intravenous infusion. The first rituximab infusion is usually slow and carefully monitored because the body may react the first time rituximab is introduced. Nurses will check your breathing, blood pressure, pulse and comfort levels throughout the infusion. After the first dose is tolerated, subsequent rituximab infusions are often given faster. The schedule for rituximab varies depending on the condition being treated. In lymphoma, rituximab is often combined with chemotherapy. In autoimmune diseases, rituximab may be given every six months or when symptoms return.

Because rituximab reduces B cells, it also affects the immune system. This means infections can become more likely while receiving rituximab. It is important to report fever, persistent cough, sore throat, painful urination or any unusual symptoms while on rituximab. Some infections can appear mild at first, so early reporting helps your team intervene quickly. Vaccinations should be reviewed before starting rituximab because rituximab reduces the ability to produce protective antibodies. Live vaccines are usually avoided, and some routine vaccines may need to be given before beginning rituximab therapy.

Infusion reactions are one of the most common effects of rituximab, particularly with the first dose. These reactions can include fever, chills, flushing, itching, headache, throat tightness, nausea or shortness of breath. Premedications such as antihistamines, paracetamol or steroids are usually given before rituximab to reduce these reactions. If an infusion reaction occurs, the rituximab drip may be slowed or temporarily stopped, then restarted once you feel better. Most patients find that infusion reactions lessen with each subsequent rituximab treatment.

RITUXIMAB can also affect blood counts. Some people develop lower white blood cell levels or reduced immunoglobulin levels after repeated rituximab doses. Blood tests are done regularly to monitor this. Rarely, rituximab can cause late onset neutropenia, where white cell counts drop several weeks or months after treatment. Your team will monitor this with follow up tests.

Liver function can also be influenced by rituximab, especially in people with prior hepatitis B infection. Rituximab can reactivate silent hepatitis B, so screening for hepatitis B is required before starting rituximab. If you have ever had hepatitis B, preventive antiviral medicine may be given throughout rituximab treatment.

RITUXIMAB may have rare but serious risks such as progressive multifocal leukoencephalopathy, a severe brain infection caused by reactivation of the JC virus. This is extremely uncommon, but it is important to report symptoms like new memory problems, weakness, difficulty walking, speech changes or vision changes while on rituximab.

Other possible effects of rituximab include fatigue, mild nausea, joint aches or temporary increases in blood pressure during the infusion. Many of these effects are manageable and tend to improve as the body adjusts to rituximab.

While taking rituximab, it is important to maintain good hygiene, avoid close contact with people who are unwell, stay hydrated and attend all scheduled blood tests. Inform your healthcare team about any new medicines or herbal supplements because rituximab may influence how your immune system responds to illness and other treatments.

Throughout your treatment, you are supported. RITUXIMAB is a powerful medicine that has helped many people with cancer or autoimmune disease achieve remission or long term control. Your doctors, nurses and I as your pharmacist will monitor your progress closely to ensure rituximab remains both safe and effective for you. You should never hesitate to ask questions or report symptoms while receiving rituximab.

Beginning rituximab is a meaningful step in your care. Even on days when treatment feels challenging, your decision to continue rituximab reflects strength, resilience and hope for better health ahead. I will walk with you through every stage of your rituximab journey and make sure you feel informed, protected and supported.